Cargando…
Glioma 2021 WHO Classification: The Superiority of NGS Over IHC in Routine Diagnostics
INTRODUCTION: The accurate detection of genetic variants such as single substitutions (IDH1/2, TERT), chromosomal abnormalities (CDKN2A, 1p/19q deletions, and EGFR amplifications), or promoter methylations (MGMT) is critical for glioma patient management, as emphasized in the World Health Organizati...
Autores principales: | Śledzińska, Paulina, Bebyn, Marek, Szczerba, Ewelina, Furtak, Jacek, Harat, Maciej, Olszewska, Natalia, Kamińska, Katarzyna, Kowalewski, Janusz, Lewandowska, Marzena A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9626418/ https://www.ncbi.nlm.nih.gov/pubmed/36053463 http://dx.doi.org/10.1007/s40291-022-00612-3 |
Ejemplares similares
-
Prognostic and Predictive Biomarkers in Gliomas
por: Śledzińska, Paulina, et al.
Publicado: (2021) -
Infratentorial Stereotactic Biopsy of Brainstem and Cerebellar Lesions
por: Furtak, Jacek, et al.
Publicado: (2021) -
BRCA1/2 Mutation Detection in the Tumor Tissue from Selected Polish Patients with Breast Cancer Using Next Generation Sequencing
por: Szczerba, Ewelina, et al.
Publicado: (2021) -
MGMT Promoter Methylation as a Prognostic Factor in Primary Glioblastoma: A Single-Institution Observational Study
por: Szylberg, Mateusz, et al.
Publicado: (2022) -
Prognostic factors in refractory metastatic colorectal cancer patients treated with Trifluridine/Tipiracil
por: Koper, Agnieszka, et al.
Publicado: (2023)